CSL has put the demerger of its Seqirus vaccination division on ice and cut its sales and profit forecasts due to a pullback ...

CSL shareholders have revolted against Australia’s largest pharmaceutical company, giving it a second strike in as many years ...

This biotech is crashing again. Let’s find out why. The post Why did CSL shares just crash 17%? appeared first on The Motley ...

SYDNEY--Shares in Australia-based pharmaceutical company CSL tumbled 15% on Tuesday after the company delayed the spinoff of its flu vaccine unit and cut annual guidance. In late morning trade Tuesday ...

We often focus on blood work for diagnostics, but urine tests hold great power mdash; sometimes uncovering things that blood ...

Shanghai-based culture media supplier JSBio has expanded from biopharma to the cultivated meat field to join China's booming ...

The International Society for Pharmaceutical Engineering (ISPE) has recognized CSL Behring as the Overall Winner of the 2025 ISPE Facility of the Year Awards (FOYA) for its Project Aurora Plasma Base ...

CSL said flu-vaccine rates in the U.S. are falling more than it expected, reflecting a shift in public attitudes toward vaccines in recent years. In the current flu season, CSL expects U.S.

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading.

CSL Limited (ASX:CSL) has tumbled nearly -15% in the first hour of Tuesday trades after the market balked at its latest AGM, ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...